[{"id":"be33c6f4-5193-44de-8e6d-d515da4df4c4","acronym":"UAB0040","url":"https://clinicaltrials.gov/study/NCT00582660","created_at":"2021-01-18T02:08:40.906Z","updated_at":"2024-07-02T16:37:21.014Z","phase":"Phase 2b","brief_title":"Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib","source_id_and_acronym":"NCT00582660 - UAB0040","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" CTNNB1 • CEACAM5 • ALOX15","pipe":"","alterations":" ","tags":["CTNNB1 • CEACAM5 • ALOX15"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e celecoxib oral"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 12/01/2001","start_date":" 12/01/2001","primary_txt":" Primary completion: 06/01/2008","primary_completion_date":" 06/01/2008","study_txt":" Completion: 06/01/2008","study_completion_date":" 06/01/2008","last_update_posted":"2017-06-15"}]